Skip to main content
Clinical Trials/TCTR20200105005
TCTR20200105005Completed未知

se of simplified HAS-BLED score for predicting bleeding events in anticoagulated patients with atrial fibrillation

o0 sites110 target enrollmentStarted: January 5, 2020Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
o
Enrollment
110

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 Years to 0 N/A (No limit) (—)
Sex
All

Inclusion Criteria

  • AF patients who were received warfarin.

Exclusion Criteria

  • 1. Contraindication of warfarin or warfarin use less than 1 year
  • 2. Each INR level was checked more than 6 months
  • 3. All types of prosthetic heart valve including mitral valve repair
  • 4. Patients with thrombocytopenia, myeloproliferative disorders (essential thrombocythemia, chronic myeloid leukemia, polycythemia vera, agnogenic myeloid metaplasia), hyperviscosity syndrome or cirrhosis
  • 5. Pregnancy
  • 6. Patients participating in other concealed study
  • 7. Warfarin interruption from surgery or invasive procedure during study
  • 8. Hospitalization during study
  • 9. Warfarin discontinuation during study

Investigators

Sponsor
o

Similar Trials

se of simplified HAS-BLED score for... | Clinical Trial